Thinking back to when I relocated home to Hong Kong in the early 1980s, the transformation of the city has been profound. From a manufacturing hub, Hong Kong has evolved into an IFC serving as a vital bridge between China and the world.
Over the decades, Hong Kong’s markets have grown increasingly vibrant and liquid, attracting some of the world’s most exciting new economy and biotech companies. At the heart of this progress is HKEX, which has played a pivotal role in shaping a resilient and dynamic IFC ecosystem through stakeholder collaboration.
Our deep connectivity with Mainland China has been at the core of everything we do, helping both markets flourish. Through Hong Kong, Mainland China opened its markets to the world, and Hong Kong leveraged this unique advantage to develop as an IFC, creating a self-reinforcing momentum, a ‘flywheel’ for progress.
I saw this up close by supporting the first batch of Mainland companies listing in Hong Kong in the early 1990s. Bringing these companies to market was bold and groundbreaking at the time, and the process was anything but easy. At my firm we sent hundreds of accountants and advisors to support the process, all the while navigating unfamiliar terrain.